Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Melanoma, Cutaneous Malignant × nintedanib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 2 Rectal Neoplasms 1 Melanoma, Cutaneous Malignant 1 Colonic Neoplasms 1

Interventions

pembrolizumab 1 nintedanib 1 dabrafenib 1 Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02308553 2020-10-14

NIPAWILMA

University Hospital, Essen

Phase 1/2 Completed

Melanoma, Cutaneous Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡